Nuveen Asset Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-21,234
| Closed | -$419K | – | 3398 |
|
|
2022
Q1 | $419K | Hold |
21,234
| – | – | ﹤0.01% | 3064 |
|
|
2021
Q4 | $411K | Sell |
21,234
-37,556
| -64% | -$727K | ﹤0.01% | 3117 |
|
|
2021
Q3 | $2.04M | Sell |
58,790
-20,467
| -26% | -$711K | ﹤0.01% | 2665 |
|
|
2021
Q2 | $4.72M | Buy |
79,257
+39,452
| +99% | +$2.35M | ﹤0.01% | 2282 |
|
|
2021
Q1 | $2.67M | Sell |
39,805
-520
| -1% | -$34.8K | ﹤0.01% | 2473 |
|
|
2020
Q4 | $2.44M | Buy |
40,325
+3,403
| +9% | +$206K | ﹤0.01% | 2411 |
|
|
2020
Q3 | $2.92M | Sell |
36,922
-1,097
| -3% | -$86.7K | ﹤0.01% | 2198 |
|
|
2020
Q2 | $2.38M | Buy |
38,019
+1,252
| +3% | +$78.3K | ﹤0.01% | 2262 |
|
|
2020
Q1 | $1.95M | Buy |
36,767
+10,563
| +40% | +$560K | ﹤0.01% | 2207 |
|
|
2019
Q4 | $3.17M | Buy |
26,204
+6,568
| +33% | +$795K | ﹤0.01% | 2224 |
|
|
2019
Q3 | $3.56M | Buy |
19,636
+2,573
| +15% | +$467K | ﹤0.01% | 2135 |
|
|
2019
Q2 | $2.22M | Buy |
+17,063
| New | +$2.22M | ﹤0.01% | 2384 |
|